FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Malgorzata Beryt

Research Profile

Disorders

Breast Neoplasms

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Pei Jin; Juan Zhang; Malgorzata Beryt; Lisa Turin; Cathleen Brdlik; Ying Feng; Xiaomei Bai; Jim Liu; Brett Jorgensen; H Michael Shepard
Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Jay Sarup; Pei Jin; Lisa Turin; Xiaomei Bai; Malgorzata Beryt; Cathleen Brdlik; Jeffrey N Higaki; Brett Jorgensen; Francis W Lau; Peter Lindley; Jim Liu; Irene Ni; James Rozzelle; Rajendra Kumari; Susan A Watson; Juan Zhang; H Michael Shepard
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
Wei-Ann Hsueh; Amanda L Kesner; Anne Gangloff; Mark D Pegram; Malgorzata Beryt; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Malgorzata Beryt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2009: Pei Jin; Juan Zhang; Malgorzata Beryt; Lisa Turin; Cathleen Brdlik; Ying Feng; Xiaomei Bai; Jim Liu; Brett Jorgensen; H Michael Shepard
Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
Molecular medicine (Cambridge, Mass.) 2009;15(1-2):11-20.
2008: Jay Sarup; Pei Jin; Lisa Turin; Xiaomei Bai; Malgorzata Beryt; Cathleen Brdlik; Jeffrey N Higaki; Brett Jorgensen; Francis W Lau; Peter Lindley; Jim Liu; Irene Ni; James Rozzelle; Rajendra Kumari; Susan A Watson; Juan Zhang; H Michael Shepard
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
Molecular cancer therapeutics 2008;7(10):3223-36.
2006: Wei-Ann Hsueh; Amanda L Kesner; Anne Gangloff; Mark D Pegram; Malgorzata Beryt; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(12):1995-9.
2005: Anne Gangloff; Wei-Ann Hsueh; Amanda L Kesner; Dale O Kiesewetter; Betty Pio; Mark D Pegram; Malgorzata Beryt; Allison Townsend; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1866-71.
2004: Mark D Pegram; Gottfried E Konecny; Carminda O'Callaghan; Malgorzata Beryt; Richard J Pietras; Dennis J Slamon
Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
Journal of the National Cancer Institute 2004;96(10):739-49.
2004: Gottfried E Konecny; Y Gloria Meng; Michael Untch; He-Jing Wang; Ingo Bauerfeind; Melinda Epstein; Petra Stieber; Jean-Michel Vernes; Johnny Gutierrez; Kyu Hong; Malgorzata Beryt; Hermann Hepp; Dennis J Slamon; Mark D Pegram
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1706-16.
2003: Gottfried E Konecny; Giovanni Pauletti; Mark D Pegram; Michael Untch; Sugandha Dandekar; Zuleima Aguilar; Cindy Wilson; Hong-Mei Rong; Ingo Bauerfeind; Margret Felber; He-Jing Wang; Malgorzata Beryt; Ram Seshadri; Hermann Hepp; Dennis J Slamon
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Journal of the National Cancer Institute 2003;95(2):142-53.
2002: Saskia T C Neuteboom; Patricia L Karjian; Christopher R Boyer; Malgorzata Beryt; Mark D Pegram; Geoffrey M Wahl; H Michael Shepard
Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
Molecular cancer therapeutics 2002;1(6):377-84.
2001: Gottfried E Konecny; M Fritz; Michael Untch; A Lebeau; Margret Felber; S Lude; Malgorzata Beryt; Hermann Hepp; Dennis J Slamon; Mark D Pegram
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer.
Breast cancer research and treatment 2001;69(1):53-63.
2001: Gottfried E Konecny; Michael Untch; J Arboleda; C Wilson; Steffen Kahlert; B Boettcher; Margret Felber; Malgorzata Beryt; S Lude; Hermann Hepp; Dennis J Slamon; Mark D Pegram
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2448-57.
2001: Gottfried E Konecny; Michael Untch; Dennis J Slamon; Malgorzata Beryt; Steffen Kahlert; Margret Felber; E Langer; S Lude; Hermann Hepp; Mark D Pegram
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
Breast cancer research and treatment 2001;67(3):223-33.
2001: D B Lackey; M P Groziak; M Sergeeva; Malgorzata Beryt; C Boyer; Robert M Stroud; PH Sayre; J W Park; P Johnston; Dennis J Slamon; H Michael Shepard; Mark D Pegram
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.
Biochemical pharmacology 2001;61(2):179-89.
1999: Mark D Pegram; S Hsu; G Lewis; Richard J Pietras; Malgorzata Beryt; Mark X Sliwkowski; D Coombs; D Baly; Fairooz Kabbinavar; Dennis J Slamon
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Oncogene 1999;18(13):2241-51.
1997: Mark D Pegram; Richard S Finn; K Arzoo; Malgorzata Beryt; Richard J Pietras; Dennis J Slamon
The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
Oncogene 1997;15(5):537-47.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.